DXCM Annual Total Liabilities
$4.20 B
+$936.00 M+28.71%
31 December 2023
Summary:
As of January 22, 2025, DXCM annual total liabilities is $4.20 billion, with the most recent change of +$936.00 million (+28.71%) on December 31, 2023. During the last 3 years, it has risen by +$1.73 billion (+70.29%). DXCM annual total liabilities is now at all-time high.DXCM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Quarterly Total Liabilities
$4.37 B
+$9.90 M+0.23%
30 September 2024
Summary:
As of January 22, 2025, DXCM quarterly total liabilities is $4.37 billion, with the most recent change of +$9.90 million (+0.23%) on September 30, 2024. Over the past year, it has increased by +$9.90 million (+0.23%). DXCM quarterly total liabilities is now -7.32% below its all-time high of $4.72 billion, reached on June 30, 2023.DXCM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DXCM Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.7% | +0.2% |
| 3 y3 years | +70.3% | +33.3% |
| 5 y5 years | +234.9% | +33.3% |
DXCM Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.1% | -7.3% | +52.5% |
| 5 y | 5-year | at high | +177.4% | -7.3% | +189.3% |
| alltime | all time | at high | >+9999.0% | -7.3% | >+9999.0% |
DexCom Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.37 B(+0.2%) |
| June 2024 | - | $4.36 B(+3.1%) |
| Mar 2024 | - | $4.24 B(+0.9%) |
| Dec 2023 | $4.20 B(+28.7%) | $4.20 B(-3.1%) |
| Sept 2023 | - | $4.33 B(-8.3%) |
| June 2023 | - | $4.72 B(+43.8%) |
| Mar 2023 | - | $3.28 B(+0.7%) |
| Dec 2022 | $3.26 B(+12.8%) | $3.26 B(+6.0%) |
| Sept 2022 | - | $3.07 B(+3.8%) |
| June 2022 | - | $2.96 B(+3.3%) |
| Mar 2022 | - | $2.87 B(-0.8%) |
| Dec 2021 | $2.89 B(+17.3%) | $2.89 B(+9.5%) |
| Sept 2021 | - | $2.64 B(+5.3%) |
| June 2021 | - | $2.51 B(+0.8%) |
| Mar 2021 | - | $2.49 B(+0.9%) |
| Dec 2020 | $2.46 B(+62.9%) | $2.46 B(+5.6%) |
| Sept 2020 | - | $2.33 B(+7.7%) |
| June 2020 | - | $2.17 B(+43.2%) |
| Mar 2020 | - | $1.51 B(+0.1%) |
| Dec 2019 | $1.51 B(+20.7%) | $1.51 B(+6.4%) |
| Sept 2019 | - | $1.42 B(+3.2%) |
| June 2019 | - | $1.38 B(+5.5%) |
| Mar 2019 | - | $1.31 B(+4.2%) |
| Dec 2018 | $1.25 B(+158.4%) | $1.25 B(+126.9%) |
| Sept 2018 | - | $552.10 M(+5.1%) |
| June 2018 | - | $525.40 M(+10.6%) |
| Mar 2018 | - | $475.10 M(-2.0%) |
| Dec 2017 | $484.70 M(+307.3%) | $484.70 M(+5.6%) |
| Sept 2017 | - | $458.90 M(+3.8%) |
| June 2017 | - | $441.90 M(+133.3%) |
| Mar 2017 | - | $189.40 M(+59.2%) |
| Dec 2016 | $119.00 M(+68.1%) | $119.00 M(+18.9%) |
| Sept 2016 | - | $100.10 M(+15.9%) |
| June 2016 | - | $86.40 M(+26.7%) |
| Mar 2016 | - | $68.20 M(-3.7%) |
| Dec 2015 | $70.80 M(+59.5%) | $70.80 M(+11.7%) |
| Sept 2015 | - | $63.40 M(+32.9%) |
| June 2015 | - | $47.70 M(+17.2%) |
| Mar 2015 | - | $40.70 M(-8.3%) |
| Dec 2014 | $44.40 M | $44.40 M(0.0%) |
| Sept 2014 | - | $44.40 M(+10.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2014 | - | $40.10 M(+14.9%) |
| Mar 2014 | - | $34.90 M(-9.1%) |
| Dec 2013 | $38.40 M(+32.4%) | $38.40 M(+8.5%) |
| Sept 2013 | - | $35.40 M(+18.0%) |
| June 2013 | - | $30.00 M(+19.0%) |
| Mar 2013 | - | $25.20 M(-13.1%) |
| Dec 2012 | $29.00 M(+81.3%) | $29.00 M(+28.6%) |
| Sept 2012 | - | $22.54 M(+17.3%) |
| June 2012 | - | $19.21 M(+4.4%) |
| Mar 2012 | - | $18.41 M(+15.1%) |
| Dec 2011 | $16.00 M(-1.1%) | $16.00 M(+1.7%) |
| Sept 2011 | - | $15.73 M(+6.3%) |
| June 2011 | - | $14.79 M(+12.1%) |
| Mar 2011 | - | $13.19 M(-18.4%) |
| Dec 2010 | $16.17 M(-75.3%) | $16.17 M(-14.3%) |
| Sept 2010 | - | $18.86 M(-3.5%) |
| June 2010 | - | $19.55 M(-9.5%) |
| Mar 2010 | - | $21.59 M(-67.0%) |
| Dec 2009 | $65.39 M(+3.2%) | $65.39 M(+3.7%) |
| Sept 2009 | - | $63.06 M(-0.1%) |
| June 2009 | - | $63.12 M(+0.5%) |
| Mar 2009 | - | $62.79 M(-0.9%) |
| Dec 2008 | $63.35 M(-9.7%) | $63.35 M(-10.0%) |
| Sept 2008 | - | $70.37 M(-1.9%) |
| June 2008 | - | $71.76 M(-0.1%) |
| Mar 2008 | - | $71.85 M(+2.4%) |
| Dec 2007 | $70.14 M(+808.0%) | $70.14 M(+2.9%) |
| Sept 2007 | - | $68.17 M(-2.4%) |
| June 2007 | - | $69.85 M(+1.1%) |
| Mar 2007 | - | $69.06 M(+794.0%) |
| Dec 2006 | $7.72 M(+5.6%) | $7.72 M(-15.9%) |
| Sept 2006 | - | $9.19 M(+38.9%) |
| June 2006 | - | $6.62 M(-8.2%) |
| Mar 2006 | - | $7.21 M(-1.5%) |
| Dec 2005 | $7.31 M(-90.7%) | $7.31 M(+131.4%) |
| Sept 2005 | - | $3.16 M(+4.8%) |
| June 2005 | - | $3.02 M(-96.2%) |
| Mar 2005 | - | $80.01 M |
| Dec 2004 | $78.67 M(+47.4%) | - |
| Dec 2003 | $53.37 M(+203.7%) | - |
| Dec 2001 | $17.57 M(+0.1%) | - |
| Dec 2000 | $17.55 M | - |
FAQ
- What is DexCom annual total liabilities?
- What is the all time high annual total liabilities for DexCom?
- What is DexCom annual total liabilities year-on-year change?
- What is DexCom quarterly total liabilities?
- What is the all time high quarterly total liabilities for DexCom?
- What is DexCom quarterly total liabilities year-on-year change?
What is DexCom annual total liabilities?
The current annual total liabilities of DXCM is $4.20 B
What is the all time high annual total liabilities for DexCom?
DexCom all-time high annual total liabilities is $4.20 B
What is DexCom annual total liabilities year-on-year change?
Over the past year, DXCM annual total liabilities has changed by +$936.00 M (+28.71%)
What is DexCom quarterly total liabilities?
The current quarterly total liabilities of DXCM is $4.37 B
What is the all time high quarterly total liabilities for DexCom?
DexCom all-time high quarterly total liabilities is $4.72 B
What is DexCom quarterly total liabilities year-on-year change?
Over the past year, DXCM quarterly total liabilities has changed by +$9.90 M (+0.23%)